| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $665K | +71.8% |
| Cost of Revenue | $1.6M | +47.2% |
| Gross Profit | -$966K | -34.0% |
| R&D Expense | $4.2M | +109.6% |
| SG&A Expense | $3.6M | -34.7% |
| Operating Income | -$9.4M | -3.6% |
| Pre-tax Income | -$9.5M | -5.4% |
| Net Income | -$9.5M | -5.4% |
| EPS (Basic) | -$1.33 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.1M | +17.7% |
| Accounts Receivable | $60K | +650.0% |
| Inventory | $630K | +277.2% |
| Current Assets | $14.1M | -30.2% |
| Total Assets | $16.9M | -28.2% |
| Current Liabilities | $2.6M | +95.5% |
| Total Liabilities | $5.1M | +30.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.1M | -3.6% |
| Capital Expenditures | $118K | -80.2% |
| Investing Cash Flow | $7.9M | +168.0% |
| Financing Cash Flow | $22.6M | +0.0% |
| Free Cash Flow | -$6.2M | +4.1% |
| +7.6% |
| Stockholders' Equity |
| $11.8M |
| -39.9% |